Vertex Pharmaceuticals Inc

NAS:VRTXHealthcareNASDAQ:NBINASDAQ:NQUSLG

$501.95+0.44%At closeAt close · Tue 20 Oct · ≈ AED 1,843.41 · Market cap $127.22B · Next earnings Mon 2 Nov · Extended $503.04 +0.22%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	88.1%	88.1%	87.9%	87.2%	86.1%	85.0%	—	—
Operating margin	46.0%	36.7%	48.2%	38.8%	−2.1%	39.4%	39.4%	+0.0 pts
Net margin	43.7%	30.9%	37.2%	36.7%	−4.9%	32.7%	32.7%	+0.0 pts
EBITDA margin	52.9%	38.5%	49.7%	46.7%	4.4%	40.3%	—	—
Return on equity	31.2%	23.2%	23.9%	20.6%	−3.3%	21.2%	21.2%	+0.0 pts
Return on assets	23.1%	17.4%	18.3%	15.9%	−2.4%	15.1%	15.1%	+0.0 pts
Return on capital employed	28.9%	24.6%	28.0%	20.0%	−1.2%	21.4%	—	—
Debt / equity	0.1×	0.1×	0.1×	0.0×	0.1×	0.2×	0.2×	+0.0%
Debt / assets	7.9%	7.2%	5.0%	3.6%	7.8%	14.9%	—	—
Interest coverage	49.1×	45.2×	78.6×	86.9×	−7.6×	357.9×	—	—
Current ratio	4.3×	4.5×	4.8×	4.0×	2.7×	2.9×	2.9×	+0.0%
Quick ratio	4.2×	4.3×	4.7×	3.8×	2.4×	2.5×	—	—
Cash ratio	3.2×	3.2×	3.8×	2.9×	1.3×	1.3×	1.3×	+0.0%
Asset turnover	0.5×	0.6×	0.5×	0.4×	0.5×	0.5×	—	—
Inventory turnover	2.6×	2.6×	2.3×	1.7×	1.3×	1.1×	—	—
Receivables turnover	7.0×	6.7×	6.2×	6.3×	6.8×	5.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—